About EVERSANA INTOUCH
As a premier life sciences agency serving pharmaceutical clients worldwide, EVERSANA INTOUCH manages hundreds of fast-paced digital projects annually—each subject to rigorous FDA compliance standards. But not long ago, fragmented testing tools, inconsistent processes, and a growing divide between manual testers and automation engineers left the quality control (QC) team struggling to keep pace.
In order to transform its testing approach, EVERSANA INTOUCH turned to Applitools. Since adopting Applitools Eyes and later expanding into Applitools Autonomous, the team has unified its end-to-end testing workflows, empowered non-technical testers, and dramatically reduced time spent on regression testing.
In a client-driven and compliance-heavy industry, speed and precision aren’t optional—they’re mandatory. Yet EVERSANA INTOUCH’s testing operation was stretched thin. The team faced three major roadblocks:
- Skill Disparities: Most testers, both inside and outside the U.S., had manual testing backgrounds. Asking them to write code for automation was unrealistic and led to delays, confusion, and missed opportunities for upskilling.
- Siloed Processes: Automation engineers often wrote scripts that manual testers couldn’t interpret or use, resulting in duplicated work and eroded trust.
- Fragmented Tooling: Using a patchwork of testing tools created inconsistencies in test coverage and high overhead in test maintenance.
All of this slowed down release cycles and, at times, allowed bugs to slip into production—a risk the team couldn’t afford.
The Solution: A Unified, Inclusive End-to-End Testing Approach
When EVERSANA INTOUCH began using Applitools Eyes, visual testing quickly became a core part of the release cycle. Compliance teams even began asking, “Did we run Applitools on this?” during defect reviews, a sign of how integral the platform had become.
The real turning point came with the addition of Applitools Autonomous, which enabled non-technical testers to build and run no-code automated tests. This made automated testing available and accessible to every single person on the team.
Why Autonomous was the Right Fit
- Lowered the Barrier to Automation: Manual testers could now build and run automated tests using a browser-based workflow, without needing deep coding expertise.
- AI-Powered Element Selection: Autonomous intelligently identifies the most stable selectors, overcoming a common pain point in coded automation—flaky tests caused by dynamic DOM structures.
- End-to-End Test Creation and Execution: Teams could create full journeys, validate visual accuracy, and run tests across multiple environments, browsers, and screen sizes in parallel.
How the Team Put it into Practice
- “AI-First” Policy: The team now evaluates if Autonomous is the right fit for all new projects before assigning a developer. This shift has helped reduce time-to-test dramatically.
- Parallel Execution: Running end-to-end tests across multiple environments and browsers simultaneously has drastically accelerated release readiness.
- CI/CD Integration: Autonomous tests now run on schedules and as part of the team’s CI/CD pipelines, using tools like Azure DevOps and Microsoft Teams for communication and tracking.
- Smarter Collaboration: Unified reporting enables developers, testers, and editors to work from the same test results, speeding up final reviews and reducing redundant work.
🎥 Dive into EVERSANA INTOUCH’s hybrid code and no-code approach to testing here
The Results: Faster Testing, Broader Participation, and Fewer Production Defects
The shift to Applitools brought tangible improvements to both the team’s workflow and outcomes:
- 65% reduction in regression testing time, largely thanks to parallel execution and reusable test flows.
- 750+ manual hours saved each month, freeing testers to focus on high-value use cases.
- 90% test stability, improving trust across stakeholders and reducing firefighting late in the release cycle.
- Inclusive automation, with non-coders now actively contributing to test automation without requiring deep programming knowledge.
- Fewer production defects, since the combination of Applitools Eyes and Autonomous catches issues before launch.
Perhaps most importantly, the use of Applitools helped cultivate a culture of quality across teams. Developers, compliance officers, and testers now operate with shared visibility, expectations, and accountability.
“We’re able to get more people involved,” said Terry. “It’s not just coverage of features—it’s coverage of people. Everyone can contribute now.”
A Sustainable Path Forward
Senior Director of QC, Eric Terry, described the transition as both strategic and human-centered. “This isn’t just about tools,” he said. “It’s about giving our people access to technologies that help them grow and stay engaged. When the pressure is high, Applitools helps us do more with less—without compromising on quality.”
In a world of compressed timelines, shifting requirements, and rising complexity, EVERSANA INTOUCH’s experience highlights a broader truth: AI isn’t replacing testers—it’s elevating them.
Applitools’ AI doesn’t just detect differences—it understands intent, flags meaningful changes, and enables teams to focus on judgment-driven work. Autonomous, in particular, shows how AI can democratize automation, reduce reliance on brittle scripts, and adapt in real time to the diverse environments and browsers common in enterprise delivery.
“The machine can do what the machine does best. That frees up our team to do what only people can do—critical thinking, edge cases, judgment,” said Terry. “That’s the real promise of AI in testing.”
The team is well-positioned to keep adapting in an industry that never stands still with Applitools as a partner.
